Foster Dykema Cabot & Partners, LLC 10x Genomics, Inc. Transaction History
Foster Dykema Cabot & Partners, LLC
- $1.19 Trillion
- Q3 2024
A detailed history of Foster Dykema Cabot & Partners, LLC transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Foster Dykema Cabot & Partners, LLC holds 12 shares of TXG stock, worth $178. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12Holding current value
$178% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding TXG
# of Institutions
296Shares Held
92.5MCall Options Held
162KPut Options Held
107K-
Vanguard Group Inc Valley Forge, PA11MShares$164 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl10.8MShares$160 Million2.31% of portfolio
-
Black Rock Inc. New York, NY6.39MShares$95.3 Million0.0% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.6.37MShares$95 Million0.1% of portfolio
-
Nikko Asset Management Americas, Inc.6.37MShares$95 Million1.67% of portfolio
About 10x Genomics, Inc.
- Ticker TXG
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 95,046,400
- Market Cap $1.42B
- Description
- 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...